Three main concepts were incorporated: (i) the condition of interest (cerebral ischemia and ischemic stroke), (ii) interventions (antioxidant peptides, peptidomimetics, and small molecules), and (iii) outcomes (histology, Nissl, TUNEL, NeuN, and neuroprotection). The gene discussed is RBFOX3; the disease is brain ischemia.